Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 16, 2011

Premium

Former chief financial officer of Myriad Genetics, Jay Moyes, has been appointed to the board of directors at Integrated Diagnostics. After his tenure at Myriad, Moyes served as chief financial officer of XDx, a molecular diagnostic company. Currently, he is director and chair of the audit committees of both Osiris Therapeutics and BioCardia.

Former vice president of sales at Myriad, Mark Willig, has been named executive vice president of North American sales at Agendia. Willig has held a number of leadership positions within the healthcare industry, including general manager and chief commercial officer at Exiqon, vice president of global sales for Thermo Fisher's anatomic pathology business unit, executive vice president of sales and marketing at Specialty Labs, as well as 12 years in commercial roles at Abbott Diagnostics. He holds a BS from the University of Missouri.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.